Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new ...

Biopharma executives shared their thoughts on the potential impacts of the new administration; Annalee Armstrong recaps JPM ...

Shares of Danish pharmaceutical giant Novo Nordisk surged close to 14% on Friday after the company announced positive results ...

The San Diego–based company’s molecules avoid the well-trod GLP-1 pathway in favor of an alternate route in the gut.

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight ...

Viking Therapeutics investors face challenges as stock plummets, cash runway helps but betting on early stage biopharma ...

Alzheimer's disease Therapeutics Market. LAS VEGAS, NV, UNITED STATES, January 23, 2025 /EINPresswire / -- DelveInsight's“Acute Respiratory Distress Synd ...

The approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.

PNT-2001 is under clinical development by Eli Lilly and Co and currently in Phase II for Metastatic ... indication benchmark for progressing into Phase III. GlobalData’s report assesses how PNT-2001’s ...

Retatrutide is under clinical development by Eli Lilly and Co and currently in Phase III for Type 2 Diabetes. According to GlobalData, Phase III drugs for Type 2 Diabetes have a 53% phase transition ...

It was a busy week of high school basketball, giving central Ohio teams a chance to make adjustments. Here are five things we ...